Thierry Philip
About
In The Last Decade
Thierry Philip
271 papers receiving 11.5k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 4.8k
- Pathology and Forensic Medicine 4.6k
- Pulmonary and Respiratory Medicine 3.3k
- Neurology 3.2k
- Molecular Biology 2.3k
Countries citing papers authored by Thierry Philip
This map shows the geographic impact of Thierry Philip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Philip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Philip more than expected).
Fields of papers citing papers by Thierry Philip
This network shows the impact of papers produced by Thierry Philip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Philip. The network helps show where Thierry Philip may publish in the future.
Co-authorship network of co-authors of Thierry Philip
This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Philip. A scholar is included among the top collaborators of Thierry Philip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Philip. Thierry Philip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 4 | |
| 3 | [To understand the words of cancer: Lexonco, dictionary of oncology SOR SAVOIR PATIENT for patients and relatives. Methodological aspects]. | 0 |
| 4 | Recommandations pour la pratique clinique : Standards, Options 2004 pour la prise en charge des patients atteints d’ostéosarcome, Mise à jour 2004 du chapitre radiothérapie, Validation du rapport initial : mars 1995,1 ère validation de la mise à jour du chapitre radiothérapie : décembre 1998, 2 e validation de la mise à jour du chapitre radiothérapie : septembre 2004 | 4 |
| 5 | Can MIBG scan replace the need for bone marrow assessment at diagnosis and reassessment in stage 4 neuroblastomas? | 7 |
| 6 | Evidence-based paediatric oncology | 4 |
| 7 | Standards, Options et Recommandations (SOR) : anatomie et cytologie pathologiques en cancérologie | 1 |
| 8 | Standards, Options and Recommendations (SOR) for diagnosis, treatment and follow-up of osteosarcoma | 2 |
| 9 | 20 yrs experience with high dose chemotherapy (HDC) in patients with metastatic and recurrent rhabdomyosarcoma (RMS). An EBMT solid tumor working party update 1998. | 1 |
| 10 | La chimioprévention du cancer du sein | 1 |
| 11 | Prognosis in patients with primary bone and/or bone marrow metastases(MET) of rhabdomyosarcoma (RMS). A joint report of the EBMT solid tumor working party and the German soft tissue sarcoma study (CWS). | 0 |
| 12 | 16 | |
| 13 | 184 | |
| 14 | Standards, options et recommandations pour une bonne pratique dans l'organisation pluridisciplinaire de la cancérologie | 6 |
| 15 | Standards, options et recommandations pour une bonne pratique en chimiothérapie | 2 |
| 16 | 30 | |
| 17 | 31 | |
| 18 | 15 | |
| 19 | 18 | |
| 20 | 50 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.